Acadia Pharma

Forecast & Rating21 analysts currently cover Acadia Pharma, with about 76.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $33.85, about 14.7% upside from the current price of $29.50. Price targets range from $17.00 to $49.00 — a wide spread, showing clear disagreement over just how much Acadia Pharma can rise. Historically, about 77.0% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Acadia Pharma closely still see room for the stock to rise. Data as of Aug 18, 2026; for reference only and not investment advice.